Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3960 results

Sort By:

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Study ID: NCT06890338
Start Date: 2025-07-28
End Date: 2029-10
Study Type

Interventional

Study Phase

Phase2

No. of Participants

140

Intervention / Treatment

Carboplatin

Mirvetuximab soravtansine

Infatuating

Sponsor

AbbVie

Source: clinicaltrials.gov

Share:
Add to list

Music and VR Effects on Pain, Anxiety, and Fear During Oral Mucositis Care in Leukaemic Children

Study ID: NCT06955338
Start Date: 2025-07-01
End Date: 2026-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

45

Intervention / Treatment

Music intervention

Virtual reality

Sponsor

Ege University

Source: clinicaltrials.gov

Share:
Add to list

Effect of SPG Block for Patients With Anxiety at Electronic Dance Music Festivals

Study ID: NCT05729503
Start Date: 2026-05-06
End Date: 2026-12-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

70

Intervention / Treatment

Lidocaine 2% Injectable Solution

Placebo

Sponsor

University of Calgary

Source: clinicaltrials.gov

Share:
Add to list

Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With Corticosteroid-refractory Chronic Graft vs. Host Disease

Study ID: NCT06824103
Start Date: 2025-11-21
End Date: 2032-01-11
Study Type

Interventional

Study Phase

Phase4

No. of Participants

50

Intervention / Treatment

Rheops

Sponsor

Novartis Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

ED-LEAD: Emergency Departments Leading the Transformation of Alzheimer's and Dementia Care

Study ID: NCT06079203
Start Date: 2025-09-01
End Date: 2027-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

19200

Intervention / Treatment

Emergency Care Redesign (ECR)

Nurse-led Telephonic Care (NLTC)

Community Paramedic-led Transitions Intervention (CPTI)

Sponsor

NYU Langone Health

Source: clinicaltrials.gov

Share:
Add to list

Implications of Circadian Variation of Human Endocannabinoid Levels on Obesity Risk

Study ID: NCT03000803
Start Date: 2025-10
End Date: 2029-10
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Early Total Caloric Intake

Late Total Caloric Intake

Sponsor

University of Chicago

Source: clinicaltrials.gov

Share:
Add to list

Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer

Study ID: NCT06980038
Start Date: 2025-10-31
End Date: 2027-05-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

44

Intervention / Treatment

Anti-CD40 Agonist Monoclonal Antibody CDX-1140

Biopsy Procedure

Biospecimen Collection

Cemiplimab

Computed Tomography

Positron Emission Tomography

Tumor Resection

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Transcutaneous Spinal Cord Stimulation in Healthy Adults

Study ID: NCT06116838
Start Date: 2025-10
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Spinal motor evoked responses (sMERs)

Continuous stimulation tolerance

Sponsor

Shirley Ryan AbilityLab

Source: clinicaltrials.gov

Share:
Add to list

Butantan-DV Vaccine in Elderly Populations (DEN-04-IB)

Study ID: NCT06891950
Start Date: 2025-07
End Date: 2026-10
Study Type

Interventional

Study Phase

Phase3

No. of Participants

997

Intervention / Treatment

Dengue 1,2,3,4 (attenuated) vaccine

Sponsor

Butantan Institute

Source: clinicaltrials.gov

Share:
Add to list

Study of NM8074 in Soliris-Treated Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Study ID: NCT05731050
Start Date: 2026-06
End Date: 2028-03
Study Type

Interventional

Study Phase

Phase2

No. of Participants

6

Intervention / Treatment

Nm8074

Sponsor

NovelMed Therapeutics

Source: clinicaltrials.gov

Share:
Add to list